JP2024100936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024100936A5 JP2024100936A5 JP2024083619A JP2024083619A JP2024100936A5 JP 2024100936 A5 JP2024100936 A5 JP 2024100936A5 JP 2024083619 A JP2024083619 A JP 2024083619A JP 2024083619 A JP2024083619 A JP 2024083619A JP 2024100936 A5 JP2024100936 A5 JP 2024100936A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid sequence
- utr
- absent
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778866P | 2018-12-12 | 2018-12-12 | |
| US201862778869P | 2018-12-12 | 2018-12-12 | |
| US62/778,866 | 2018-12-12 | ||
| US62/778,869 | 2018-12-12 | ||
| JP2021533524A JP2022512395A (ja) | 2018-12-12 | 2019-12-12 | 分泌治療モダリティを送達するためのアネロソーム |
| PCT/US2019/065919 WO2020123773A2 (en) | 2018-12-12 | 2019-12-12 | Anellosomes for delivering secreted therapeutic modalities |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533524A Division JP2022512395A (ja) | 2018-12-12 | 2019-12-12 | 分泌治療モダリティを送達するためのアネロソーム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024100936A JP2024100936A (ja) | 2024-07-26 |
| JP2024100936A5 true JP2024100936A5 (cg-RX-API-DMAC10.html) | 2024-10-31 |
Family
ID=69160343
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533524A Pending JP2022512395A (ja) | 2018-12-12 | 2019-12-12 | 分泌治療モダリティを送達するためのアネロソーム |
| JP2024083619A Pending JP2024100936A (ja) | 2018-12-12 | 2024-05-22 | 分泌治療モダリティを送達するためのアネロソーム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533524A Pending JP2022512395A (ja) | 2018-12-12 | 2019-12-12 | 分泌治療モダリティを送達するためのアネロソーム |
Country Status (11)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11624061B2 (en) | 2017-04-28 | 2023-04-11 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| BR112020005803A2 (pt) | 2017-09-25 | 2020-12-01 | Agrospheres, Inc. | composições e métodos para produção e administração moduláveis de produtos biológicos |
| JP2022513459A (ja) * | 2018-12-12 | 2022-02-08 | フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド | タンパク質代替治療モダリティを送達するためのアネロソーム |
| CA3121528A1 (en) | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes and methods of use |
| KR20230041686A (ko) * | 2020-06-17 | 2023-03-24 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 아넬로바이러스를 확인 및 특징화하는 방법 및 이의 용도 |
| US20240000914A1 (en) * | 2020-10-29 | 2024-01-04 | Flagship Pioneering Innovations V, Inc. | Chicken anemia virus (cav)-based vectors |
| WO2022170195A1 (en) * | 2021-02-08 | 2022-08-11 | Flagship Pioneering Innovations V, Inc. | Hybrid aav-anellovectors |
| EP4337235A4 (en) * | 2021-05-12 | 2025-07-02 | Flagship Pioneering Innovations V Inc | ANELLOVECTORS AND METHODS OF USE |
| CN118284411A (zh) * | 2021-10-12 | 2024-07-02 | 旗舰先锋创新V股份有限公司 | 新颖的指环载体组合物和方法 |
| MX2024004492A (es) * | 2021-10-12 | 2024-05-31 | Flagship Pioneering Innovations V Inc | Composiciones y metodos de anellovector novedosos. |
| TW202430215A (zh) | 2022-12-14 | 2024-08-01 | 美商旗艦先鋒創新有限責任(Vii)公司 | 用於將治療劑遞送至骨之組成物和方法 |
| TW202529819A (zh) | 2023-10-13 | 2025-08-01 | 美商旗艦先鋒創新公司 | 組織特異性指環載體(anellovector)遞送 |
| CN117695410B (zh) * | 2024-02-06 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | CRISPR/Cas9纳米抗菌剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
| CN111206032B (zh) * | 2013-12-12 | 2024-07-19 | 布罗德研究所有限公司 | 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用 |
| EP3359663A4 (en) * | 2015-09-24 | 2019-08-14 | The Trustees of The University of Pennsylvania | COMPOSITION AND METHOD FOR THE TREATMENT OF A COMPLEMENT-MEDIATED DISEASE |
| CA3066750A1 (en) * | 2017-06-13 | 2018-12-20 | Flagship Pioneering Innovations V, Inc. | Compositions comprising curons and uses thereof |
| KR20200067195A (ko) * | 2017-10-18 | 2020-06-11 | 리젠엑스바이오 인크. | 완전-인간 번역후 변형된 항체 치료제 |
-
2019
- 2019-12-12 US US17/413,207 patent/US20230048858A1/en not_active Abandoned
- 2019-12-12 JP JP2021533524A patent/JP2022512395A/ja active Pending
- 2019-12-12 CN CN201980091251.6A patent/CN113631717A/zh active Pending
- 2019-12-12 AU AU2019396520A patent/AU2019396520A1/en not_active Abandoned
- 2019-12-12 KR KR1020217021775A patent/KR20210131309A/ko not_active Ceased
- 2019-12-12 BR BR112021009379-6A patent/BR112021009379A2/pt unknown
- 2019-12-12 CA CA3119531A patent/CA3119531A1/en active Pending
- 2019-12-12 EP EP19836323.6A patent/EP3894568A2/en active Pending
- 2019-12-12 WO PCT/US2019/065919 patent/WO2020123773A2/en not_active Ceased
- 2019-12-12 MX MX2021006943A patent/MX2021006943A/es unknown
-
2021
- 2021-06-07 IL IL283778A patent/IL283778A/en unknown
-
2024
- 2024-05-22 JP JP2024083619A patent/JP2024100936A/ja active Pending
-
2025
- 2025-06-17 US US19/240,368 patent/US20260009050A1/en active Pending